Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation

Autor: Hodkinson, Brendan P. Oncology Translational Research (Estats Units d'Amèrica), Schaffer, Michael, Brody, Joshua D., Jurczak, Wojciech, Carpio Segura, Cecilia del Carmen, Ben-Yehuda, Dina, Avivi, Irit, Forslund, Ann, Özcan, Muhit, Alvarez, John, Ceulemans, Rob, Fourneau, Nele, Younes, Anas, Balasubramanian, Sriram, Universitat Autònoma de Barcelona

Publikováno v: Translational Oncology
Translational Oncology, Vol 14, Iss 1, Pp 100977-(2021)
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Highlights • Biomarkers of response to ibrutinib + nivolumab were analyzed in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma and Richter transformation. • DLBCL patients with elevated PD-L1 by immunohistochemistry tended to have bette

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa065b6f8a558595699c63e7b7068433
https://doi.org/10.1016/j.tranon.2020.100977